R&D The future of Oxford: Science, technology, and collaboration In conversation with Professor Lady Sue Black and Simon Ruck about Oxford North, from opening to today.
R&D Sponsored The UK life sciences sector at a crossroads: Bold decisions ... We all want the same thing: for the UK to succeed, for our workforces to thrive, and for patients and the NHS to benefit.
Market Access Health, growth & renewal: ABPI 2026 looks to UK’s future The Association of the British Pharmaceutical Industry (ABPI)'s flagship annual conference took place on Thursday, 23rd April.
News UK Knowledge Quarter welcomes Boehringer Ingelheim AI accele... Boehringer Ingelheim has announced expansion of its global Computational Innovation footprint with a new centre dedicated to AI & ML in the UK.
R&D Why the government’s latest funding push is critical to the ... Many of the UK’s most promising life sciences innovations continue to face persistent funding challenges, made worse by an increasingly volatile globa
R&D From physics to pharma: How Aqemia is reinventing the future... The UK life sciences sector has long been a crucible for innovation, blending academic excellence with a thriving ecosystem of biotech and pharmaceutical enterprises.
News TransThera's resistant biliary cancer drug cleared in China TransThera's Yochanra has been cleared in China as the world's first drug that can overcome resistance to FGFR inhibitors in cholangiocarcinoma.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
